124 related articles for article (PubMed ID: 10612524)
1. Irreversible corneal decompensation in patients treated with topical dorzolamide.
Adamsons I
Am J Ophthalmol; 1999 Dec; 128(6):774-6. PubMed ID: 10612524
[No Abstract] [Full Text] [Related]
2. Irreversible corneal decompensation in patients treated with topical dorzolamide.
Konowal A; Morrison JC; Brown SV; Cooke DL; Maguire LJ; Verdier DV; Fraunfelder FT; Dennis RF; Epstein RJ
Am J Ophthalmol; 1999 Apr; 127(4):403-6. PubMed ID: 10218692
[TBL] [Abstract][Full Text] [Related]
3. Combination of systemic acetazolamide and topical dorzolamide.
Epstein R; Brown SV; Dennis RF; Konowal-Allen A
Ophthalmology; 1998 Sep; 105(9):1581-2. PubMed ID: 9754157
[No Abstract] [Full Text] [Related]
4. Erythema multiforme after use of topical dorzolamide.
Munshi V; Ahluwalia H
J Ocul Pharmacol Ther; 2008 Feb; 24(1):91-3. PubMed ID: 18370879
[TBL] [Abstract][Full Text] [Related]
5. Endothelial changes associated with topical dorzolamide do appear to be significant.
Epstein RJ; Brown SV; Konowal A
Arch Ophthalmol; 2004 Jul; 122(7):1089; author reply 1090. PubMed ID: 15249392
[No Abstract] [Full Text] [Related]
6. Marginal keratitis: an uncommon form of topical dorzolamide allergy.
Taguri AH; Khan MA; Sanders R
Am J Ophthalmol; 2000 Jul; 130(1):120-2. PubMed ID: 11004272
[TBL] [Abstract][Full Text] [Related]
7. Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension.
Tanimura H; Minamoto A; Narai A; Hirayama T; Suzuki M; Mishima HK
Jpn J Ophthalmol; 2005; 49(4):332-3. PubMed ID: 16075340
[No Abstract] [Full Text] [Related]
8. [Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
Gafencu O; Armegioiu M; Ionita M
Oftalmologia; 1997; 41(1):66-8. PubMed ID: 9138500
[TBL] [Abstract][Full Text] [Related]
9. [Local carbonic anhydrase inhibitor dorzolamide: development and properties].
Pfeiffer N
Ophthalmologe; 1996 Feb; 93(1):103-18. PubMed ID: 8867167
[No Abstract] [Full Text] [Related]
10. Brinzolamide induced reversible corneal decompensation.
Zhao JC; Chen T
Br J Ophthalmol; 2005 Mar; 89(3):389-90. PubMed ID: 15722328
[No Abstract] [Full Text] [Related]
11. Topical dorzolamide-induced hypotony and ciliochoroidal detachment in patients with previous filtration surgery.
Fineman MS; Katz LJ; Wilson RP
Arch Ophthalmol; 1996 Aug; 114(8):1031-2. PubMed ID: 8694722
[No Abstract] [Full Text] [Related]
12. Nephrolithiasis with dorzolamide.
Carlsen J; Durcan J; Zabriskie N; Swartz M; Crandall A
Arch Ophthalmol; 1999 Aug; 117(8):1087-8. PubMed ID: 10448757
[No Abstract] [Full Text] [Related]
13. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
[TBL] [Abstract][Full Text] [Related]
14. Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.
Wirtitsch MG; Findl O; Heinzl H; Drexler W
Arch Ophthalmol; 2007 Oct; 125(10):1345-50. PubMed ID: 17923541
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and safety of dorzolamide 2% in addition to multiple topical antiglaucoma medications.
Le HH; Chang MR; Cheng Q; Lee DA; Hartenbaum D
J Ocul Pharmacol Ther; 1999 Aug; 15(4):305-12. PubMed ID: 10463869
[TBL] [Abstract][Full Text] [Related]
16. Allergic contact blepharoconjunctivitis from dorzolamide.
Mancuso G; Berdondini RM
Contact Dermatitis; 2001 Oct; 45(4):243. PubMed ID: 11683843
[No Abstract] [Full Text] [Related]
17. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
Sugrue MF
J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343
[TBL] [Abstract][Full Text] [Related]
18. Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma.
Beckwith-Cohen B; Bentley E; Gasper DJ; McLellan GJ; Dubielzig RR
J Am Vet Med Assoc; 2015 Dec; 247(12):1419-26. PubMed ID: 26642138
[TBL] [Abstract][Full Text] [Related]
19. Topical dorzolamide and metabolic acidosis in a neonate.
Morris S; Geh V; Nischal KK; Sahi S; Ahmed MA
Br J Ophthalmol; 2003 Aug; 87(8):1052-3. PubMed ID: 12881361
[No Abstract] [Full Text] [Related]
20. Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function.
Hoffmanová I; Sánchez D
Br J Clin Pharmacol; 2018 Apr; 84(4):796-799. PubMed ID: 29333622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
